Literature DB >> 33659531

Testing Bone Formation Induction by Calvarial Injection Assay in vivo.

Narelle E McGregor1, Ingrid J Poulton1, Emma C Walker1, Natalie A Sims1,2.   

Abstract

Bone formation occurs during embryogenesis, skeletal growth and during the process of skeletal renewal throughout life. In the process of bone formation, osteoblasts lay down a collagen-containing matrix, termed osteoid, which is gradually hardened by incorporation of mineral crystals. Although osteoblasts can be induced to differentiate and to deposit mineral in culture, this system does not always provide results that reflect the ability of agents to stimulate bone formation in vivo. This protocol describes a rapid and reliable method for testing local administration of agents on bone formation in vivo. In this method, mice are injected with the agent of question for 5 successive days. Fluorochrome labels are injected prior to, and after agents used for testing, and samples are collected and analysed by undecalcified bone histology and histomorphometry. This provides a robust method for assessing the ability of agents to stimulate bone formation, and if a short-term modification is used, can also be used for testing gene responses in bone to the same stimuli.
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Bone formation; Cytokines; Growth factors; Osteoblast; Osteocyte

Year:  2020        PMID: 33659531      PMCID: PMC7842514          DOI: 10.21769/BioProtoc.3560

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  18 in total

1.  Differentiation potential of a mouse bone marrow stromal cell line.

Authors:  Elizabeth H Allan; Patricia W M Ho; Akihro Umezawa; Jun-Ichi Hata; Fusao Makishima; Matthew T Gillespie; T John Martin
Journal:  J Cell Biochem       Date:  2003-09-01       Impact factor: 4.429

Review 2.  Dynamics of the transition from osteoblast to osteocyte.

Authors:  Sarah L Dallas; Lynda F Bonewald
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

Review 3.  Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown.

Authors:  Martha Blank; Natalie A Sims
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

4.  Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor.

Authors:  D Metcalf; D P Gearing
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.

Authors:  Luc Malaval; Fina Liu; Ann B Vernallis; Jane E Aubin
Journal:  J Cell Physiol       Date:  2005-08       Impact factor: 6.384

6.  LIF inhibits osteoblast differentiation at least in part by regulation of HAS2 and its product hyaluronan.

Authors:  Dominic Falconi; Jane E Aubin
Journal:  J Bone Miner Res       Date:  2007-08       Impact factor: 6.741

7.  The effect of leukemia inhibitory factor on bone in vivo.

Authors:  J Cornish; K Callon; A King; S Edgar; I R Reid
Journal:  Endocrinology       Date:  1993-03       Impact factor: 4.736

8.  Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.

Authors:  L D Quarles; D A Yohay; L W Lever; R Caton; R J Wenstrup
Journal:  J Bone Miner Res       Date:  1992-06       Impact factor: 6.741

9.  Increased autophagy in EphrinB2-deficient osteocytes is associated with elevated secondary mineralization and brittle bone.

Authors:  Christina Vrahnas; Martha Blank; Toby A Dite; Liliana Tatarczuch; Niloufar Ansari; Blessing Crimeen-Irwin; Huynh Nguyen; Mark R Forwood; Yifang Hu; Mika Ikegame; Keith R Bambery; Cyril Petibois; Eleanor J Mackie; Mark J Tobin; Gordon K Smyth; Jonathan S Oakhill; T John Martin; Natalie A Sims
Journal:  Nat Commun       Date:  2019-07-31       Impact factor: 14.919

10.  Optimisation of the differing conditions required for bone formation in vitro by primary osteoblasts from mice and rats.

Authors:  Isabel R Orriss; Mark O R Hajjawi; Carmen Huesa; Vicky E MacRae; Timothy R Arnett
Journal:  Int J Mol Med       Date:  2014-09-08       Impact factor: 4.101

View more
  1 in total

1.  The effect of carbamazepine on bone structure and strength in control and osteogenesis imperfecta (Col1a2 +/p.G610C ) mice.

Authors:  Martha Blank; Narelle E McGregor; Lynn Rowley; Louise H W Kung; Blessing Crimeen-Irwin; Ingrid J Poulton; Emma C Walker; Jonathan H Gooi; Shireen R Lamandé; Natalie A Sims; John F Bateman
Journal:  J Cell Mol Med       Date:  2022-06-14       Impact factor: 5.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.